Coiled Therapeutics plans to report initial safety and pharmacokinetic data for its new AO-252 cancer drug formulation by the end of 2026 after dosing up to 30 patients. The new lipid-based softgel aims to improve drug absorption and consistency, with early trials showing promising tumor stabilization and shrinkage. A larger safety and efficacy dataset is expected in 2027 to guide further development and partnership discussions. The company recently secured licensing, raised £8.5 million, and restructured its leadership to support ongoing development.
Coiled Therapeutics' new AO-252 formulation is the subject, with Pluang's Health sector data providing market context as of Sep 28, 2026 14:21 WIB. Of 100 priced Health-sector US stocks tradable on Pluang, 40 rose and 51 fell today. Notable movers include ADPT at USD 28.72 with a -2.41% change, CRON at USD 3.34 with a -1.76% change, and CTXR at USD 0.58 with a +1.76% change, with ADPT showing the largest price decline.
NEAR Protocol's price surged from below $2 to over $5, peaking near $5.42 before a slight pullback, fueled by the anticipation of Bitwise's U.S. spot NEAR ETF launch. Technical indicators like RSI at 79.91 show overbought conditions, while MACD remai...
Bitcoin is trading around $82,949, about 5% below its 2026 start, with potential to reclaim $87,500 and end the year in the green. Spot buying has increased, pushing prices toward $86,000, supported by strong institutional demand via U.S. spot Bitcoi...
Cardano (ADA) price remains just under the $0.26 resistance after an 11.5% weekly rise, showing signs of consolidation. Futures market data presents mixed signals with a low long-to-short ratio suggesting bearish sentiment, while positive funding rat...
SoFi Bank has launched SoFiUSD, its own stablecoin, to settle over $25 billion annually through Mastercard's global payments network, moving from pilot to live production. This bank-issued stablecoin is redeemable 1:1 for U.S. dollars and backed by c...
The Liberty All-Star Growth Fund (ASG), a closed-end fund investing across market caps, is currently trading at a significant discount due to both widening discount levels and relatively weak portfolio performance. While the fund has a stronger long-...
